{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:50:32Z","timestamp":1761418232128},"reference-count":42,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.vaccine.2003.12.009","type":"journal-article","created":{"date-parts":[[2004,1,22]],"date-time":"2004-01-22T10:20:17Z","timestamp":1074766817000},"page":"2617-2625","source":"Crossref","is-referenced-by-count":12,"title":["Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock"],"prefix":"10.1016","volume":"22","author":[{"given":"Ellen","family":"Jessouroun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivna F.B.","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a P.","family":"Larangeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Frasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo C.","family":"Castro-Faria-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia T.","family":"Bozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2003.12.009_BIB1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/159.2.195","article-title":"Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease","volume":"159","author":"Brandtzaeg","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09537100220122448","article-title":"Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis","volume":"13","author":"Mirlashari","year":"2002","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.vaccine.2003.12.009_BIB3","first-page":"41","article-title":"The hyperferremic mouse model for the evaluation of the effectiveness of VA-MENGOC-BC against Neisseria meningitidis B clinical isolates","volume":"28","author":"Sifontes","year":"1997","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.vaccine.2003.12.009_BIB4","first-page":"34","article-title":"Meningococcal lipopolysaccharides: virulence factor and potential vaccine component","volume":"57","author":"Verheul","year":"1993","journal-title":"Microbiol. Ver."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000164100","article-title":"Immunization with meningococcal membrane-bound lipoolygosaccharide accelerates granulocyte recovery and enhances lymphocyte proliferation in myelosuppressed mice","volume":"65","author":"Quakyi","year":"1997","journal-title":"Pathobiol."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB6","first-page":"13","article-title":"Development of a meningococcal vaccine","volume":"4","author":"Poolman","year":"1995","journal-title":"Infect. Agents Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2003.12.009_BIB7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-1157(89)90017-6","article-title":"Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage","volume":"17","author":"Tsai","year":"1989","journal-title":"J. Biol. Stand."},{"issue":"4","key":"10.1016\/j.vaccine.2003.12.009_BIB8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0264-410X(89)90194-1","article-title":"Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay","volume":"7","author":"Saukkonen","year":"1989","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2003.12.009_BIB9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0264-410X(93)90045-Y","article-title":"Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals","volume":"11","author":"Danve","year":"1993","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2003.12.009_BIB10","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/IAI.58.9.2875-2881.1990","article-title":"Expression of Neisseria meningitidis iron-regulated outer membrane proteins, including 70 kilodalton transferrin receptor, and their potential for use as vaccines","volume":"58","author":"Banerjee-Bhatnagar","year":"1990","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(95)00136-O","article-title":"The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains","volume":"14","author":"Ala\u2019Aldeen","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2003.12.009_BIB12","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.67.5.2441-2451.1999","article-title":"Humoral immune response to Neisseria meningitidis in children","volume":"67","author":"Pollard","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/128.2.178","article-title":"Nutritional profiles of Neisseria gonorrhorae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirement for gonococcal typing","volume":"128","author":"Catlin","year":"1973","journal-title":"J. Infec. Dis."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nbt0295-170","article-title":"Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex","volume":"13","author":"Fu","year":"1995","journal-title":"Biotechnology"},{"issue":"4","key":"10.1016\/j.vaccine.2003.12.009_BIB15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S0036-46651994000400002","article-title":"Induction of iron regulated proteins during normal growth of N. meningitidis in a chemically defined medium","volume":"36","author":"Brandileone","year":"1994","journal-title":"Rev. Inst. Med. Trop. (S\u00e3o Paulo)"},{"key":"10.1016\/j.vaccine.2003.12.009_BIB16","first-page":"1","article-title":"Immune response of mice to a Brazilian group B vaccine","volume":"561","author":"Milagres","year":"1995","journal-title":"FEEMS Immunol. Med. Microb."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2003.12.009_BIB18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0003-2697(78)90586-9","article-title":"A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples","volume":"87","author":"Markwell","year":"1978","journal-title":"Anal. Biochnol."},{"issue":"10","key":"10.1016\/j.vaccine.2003.12.009_BIB19","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.vaccine.2003.12.009_BIB20","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody response to meningococcal outer membrane antigens after three doses of Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB21","unstructured":"Lima AO, Soares JB, Greco JB, Galizzi J, Can\u00e7ado JR. M\u00e9todos de laborat\u00f3rio aplicados \u00e0 cl\u0131\u0301nica. 5a edi\u00e7\u00e3o. Guanabara Koogan; 1977."},{"issue":"4","key":"10.1016\/j.vaccine.2003.12.009_BIB22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1055\/s-0038-1647127","article-title":"Platelet mobilization induced by PAF and its role in the thrombocytosis triggered by adrenaline in rats","volume":"62","author":"Castro-Faria-Neto","year":"1989","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.vaccine.2003.12.009_BIB23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/IAI.65.5.1972-1979.1997","article-title":"Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity","volume":"65","author":"Quakyi","year":"1997","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.vaccine.2003.12.009_BIB24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/09680519000060060501","article-title":"Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide","volume":"6","author":"Bjerre","year":"2000","journal-title":"J. Endotoxin Res."},{"issue":"7","key":"10.1016\/j.vaccine.2003.12.009_BIB25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","article-title":"Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection","volume":"185","author":"Martin","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/166.3.650","article-title":"Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease","volume":"166","author":"Brandtzaeg","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0065-2776(08)60597-0","article-title":"Role of cytokines in sepsis","volume":"66","author":"Hack","year":"1997","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2003.12.009_BIB28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2249.1998.00715.x","article-title":"Endotoxin release and cytokine production in acute and chronic meningococcaemia","volume":"114","author":"Prins","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/infdis\/167.2.471","article-title":"Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease","volume":"167","author":"Halstensen","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB30","first-page":"13","article-title":"Molecular mechanism in tolerance to lipopolysaccharide","volume":"45","author":"Ziegler-Heitbrock","year":"1995","journal-title":"J. Inflamm."},{"issue":"8","key":"10.1016\/j.vaccine.2003.12.009_BIB31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/JCM.26.8.1543-1548.1988","article-title":"Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection","volume":"26","author":"Rosenqvist","year":"1988","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.vaccine.2003.12.009_BIB32","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1128\/IAI.57.5.1590-1598.1989","article-title":"Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination","volume":"57","author":"Mandrell","year":"1989","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.vaccine.2003.12.009_BIB33","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1128\/JCM.39.8.2897-2903.2001","article-title":"Serosubtypes and PorA types of Neisseria meningitides serogroup B isolated in Brazil during 1997\u20131998: overview and implications for vaccine development","volume":"39","author":"Sacchi","year":"2001","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.12.009_BIB34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2003.12.009_BIB35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.12.009_BIB36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1086\/314927","article-title":"Immunization with meningococcal outer membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock","volume":"180","author":"Quakyi","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.vaccine.2003.12.009_BIB37","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1128\/IAI.67.10.4988-4993.1999","article-title":"Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response","volume":"67","author":"Steeghs","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB38","first-page":"85","article-title":"Expression of iron-regulated outer membrane protein in Neisseria meningitidis: a comparison of three culture media","volume":"51","author":"Jessouroun","year":"1995","journal-title":"Biomed. Lett."},{"key":"10.1016\/j.vaccine.2003.12.009_BIB39","unstructured":"Centro Nacional de Biopreparados. Vaccine against group B Neisseria meningitidis, gamaglobulin and tranfer factor. European Patent Specification, 0301992B1, Bulletin 1989."},{"issue":"14","key":"10.1016\/j.vaccine.2003.12.009_BIB40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines-current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.12.009_BIB41","doi-asserted-by":"crossref","unstructured":"Heumann D, Roger T. Initial responses to endotoxin and Gram-negative bacteria. Clin Chim Acta 2002;59\u201372.","DOI":"10.1016\/S0009-8981(02)00180-8"},{"key":"10.1016\/j.vaccine.2003.12.009_BIB42","first-page":"119","article-title":"The cellular response in sepsis","volume":"216","author":"Pajkrt","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T06:17:00Z","timestamp":1585462620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":42,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0264410X03008740"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.12.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}